calendar
23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma
23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma
no tagged catalysts yet
Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: TABLET. Route: ORAL
Sponsor: COSETTE. Form: SYRUP. Route: ORAL
Sponsor: IPCA LABS LTD. Form: TABLET. Route: ORAL
Sponsor: PH HEALTH. Form: INJECTABLE. Route: INJECTION
Sponsor: PH HEALTH. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: HETERO LABS LTD V. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA LTD. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: IMPAX LABS. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: MPP PHARMA. Form: TABLET. Route: ORAL
Sponsor: ALKEM LABS LTD. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: GLAND. Form: INJECTABLE. Route: INJECTION
GM grant. $132,000. PI: Rebecca E Scully
Sponsor: VANDA PHARMS INC. Form: CAPSULE. Route: ORAL
Sponsor: SAGENT. Form: SOLUTION. Route: INTRAVENOUS
MH grant. $181,224. PI: ALISA MO
Sponsor: ACTAVIS ELIZABETH. Form: TABLET. Route: SUBLINGUAL
Sponsor: SANALUZ. Form: TABLET. Route: ORAL
Sponsor: SANALUZ. Form: TABLET. Route: ORAL
Sponsor: SCINOPHARM TAIWAN. Form: INJECTABLE. Route: SUBCUTANEOUS
Sponsor: AUROBINDO PHARMA USA. Form: TABLET, DELAYED RELEASE. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: AUROLIFE PHARMA LLC. Form: TABLET. Route: ORAL
Sponsor: PHARMOBEDIENT. Form: SOLUTION. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL
Sponsor: UPSHER SMITH LABS. Form: TABLET. Route: ORAL
Sponsor: SPECGX LLC. Form: TABLET. Route: ORAL
Sponsor: RK PHARMA. Form: SOLUTION. Route: INTRAVENOUS
Sponsor: AVION PHARMS. Form: CAPSULE. Route: ORAL
Sponsor: AUROBINDO PHARMA. Form: TABLET, FOR SUSPENSION. Route: ORAL
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: SENORES PHARMS. Form: TABLET. Route: ORAL
Sponsor: UMEDICA. Form: TABLET. Route: ORAL
AG grant. $75,520. PI: Wesley T Richerson
AG grant. $49,538. PI: Dante Dennis Verendia Acenas II
HD grant. $49,538. PI: Alison Guyer
CA grant. $407,412. PI: Bryan Michael Burt
VA grant. PI: MICHAEL E. MATHENY
DC grant. $82,540. PI: Byron Howard Price
AG grant. $457,112. PI: Marcus E. Peter
AG grant. $695,789. PI: Michael Bienkowski
HL grant. $41,057. PI: Jesse Buffington
AG grant. $323,825. PI: Shariq Mohammed
DC grant. $238,502. PI: Lisa Soyeon Baik
AI grant. $85,563. PI: Vivek Kapur